Juliette Berangere Audet insider trades
Open-market stock purchases and sales by Juliette Berangere Audet, See Remarks at NewAmsterdam Pharma Co NV, from SEC Form 4 filings since Apr 1, 2024.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +101%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- NAMS NewAmsterdam Pharma Co NV: 1 buy, last May 1, 2025
Get free alerts when Juliette Berangere Audet files a new trade →